A critical advance in cancer investigation is emerging with the use of VHH fragments to re-engage mutated p53. This vital cancer inhibitor protein is frequently disabled in several kinds of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research